Tropomyosin receptor kinase (TRK) biology and the role of NTRK gene fusions in cancer

被引:189
作者
Amatu, A. [1 ]
Sartore-Bianchi, A. [1 ,2 ]
Bencardino, K. [1 ]
Pizzutilo, E. G. [1 ,2 ]
Tosi, F. [1 ,2 ]
Siena, S. [1 ,2 ]
机构
[1] Grande Osped Metropolitano Niguarda, Niguarda Canc Ctr, Dept Hematol & Oncol, Piazza Osped Maggiore 3, I-20162 Milan, Italy
[2] Univ Milan, Dept Oncol & Hematooncol, Milan, Italy
基金
欧盟地平线“2020”;
关键词
TRK; tropomyosin receptor kinase; NTRK gene fusions; TRK fusion cancer; NERVE GROWTH-FACTOR; TYROSINE PROTEIN-KINASE; NEUROTROPHIC FACTOR; MESOBLASTIC NEPHROMA; TARGETED THERAPY; CONGENITAL INSENSITIVITY; INHIBITOR ENTRECTINIB; PROTOONCOGENE PRODUCT; ACQUIRED-RESISTANCE; HIGH-FREQUENCY;
D O I
10.1093/annonc/mdz383
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The tropomyosin receptor kinase (TRK) family of receptor tyrosine kinases are encoded by NTRK genes and have a role in the development and normal functioning of the nervous system. Since the discovery of an oncogenic NTRK gene fusion in colorectal cancer in 1986, over 80 different fusion partner genes have been identified in a wide array of adult and paediatric tumours, providing actionable targets for targeted therapy. This review describes the normal function and physiology of TRK receptors and the biology behind NTRK gene fusions and how they act as oncogenic drivers in cancer. Finally, an overview of the incidence and prevalence of NTRK gene fusions in various types of cancers is discussed.
引用
收藏
页码:VIII5 / VIII15
页数:11
相关论文
共 122 条
  • [71] NTRK1 rearrangement in colorectal cancer patients: evidence for actionable target using patient-derived tumor cell line
    Lee, Su Jin
    Li, Gang Gary
    Kim, Seung Tae
    Hong, Min Eui
    Jang, Jiryeon
    Yoon, Nara
    Ahn, Soo Min
    Murphy, Danielle
    Christiansen, Jason
    Wei, Ge
    Hornby, Zachary
    Lee, Dong Woo
    Park, Joon Oh
    Park, Young Suk
    Lim, Ho Yeong
    Hong, Sung No
    Kim, Seok-Hyeong
    Kang, Won Ki
    Park, Keunchil
    Park, Woong Yang
    Kim, Kyoung-Mee
    Lee, Jeeyun
    [J]. ONCOTARGET, 2015, 6 (36) : 39028 - 39035
  • [72] ETV6-NTRK3 Is a Common Chromosomal Rearrangement in Radiation-Associated Thyroid Cancer
    Leeman-Neill, Rebecca J.
    Kelly, Lindsey M.
    Liu, Pengyuan
    Brenner, Alina V.
    Little, Mark P.
    Bogdanova, Tetiana I.
    Evdokimova, Viktoria N.
    Hatch, Maureen
    Zurnadzy, Liudmyla Y.
    Nikiforova, Marina N.
    Yue, Ning J.
    Zhang, Miao
    Mabuchi, Kiyohiko
    Tronko, Mykola D.
    Nikiforov, Yuri E.
    [J]. CANCER, 2014, 120 (06) : 799 - 807
  • [73] Primary and Metastatic Melanoma With NTRK Fusions
    Lezcano, Cecilia
    Shoushtari, Alexander N.
    Ariyan, Charlotte
    Hollmann, Travis J.
    Busam, Klaus J.
    [J]. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2018, 42 (08) : 1052 - 1058
  • [74] ETV6-NTRK3 fusion oncogene initiates breast cancer from committed mammary progenitors via activation of AP1 complex
    Li, Zhe
    Tognon, Cristina E.
    Godinho, Frank J.
    Yasaitis, Laura
    Hock, Hanno
    Herschkowitz, Jason I.
    Lannon, Chris L.
    Cho, Eunah
    Kim, Seong-Jin
    Bronson, Roderick T.
    Perou, Charles M.
    Sorensen, Poul H.
    Orkin, Stuart H.
    [J]. CANCER CELL, 2007, 12 (06) : 542 - 558
  • [75] Louis D.N., 2016, WHO CLASSIFICATION T, V1
  • [76] A HUMAN ONCOGENE FORMED BY THE FUSION OF TRUNCATED TROPOMYOSIN AND PROTEIN TYROSINE KINASE SEQUENCES
    MARTINZANCA, D
    HUGHES, SH
    BARBACID, M
    [J]. NATURE, 1986, 319 (6056) : 743 - 748
  • [77] TRKA expression and NTRK1 gene copy number across solid tumours
    Mauri, Gianluca
    Valtorta, Emanuele
    Cerea, Giulio
    Amatu, Alessio
    Schirru, Michele
    Marrapese, Giovanna
    Fiorillo, Vincenzo
    Recchimuzzo, Patrizia
    Cavenago, Ivana Stella
    Bonazzina, Erica Francesca
    Motta, Valentina
    Lauricella, Calogero
    Veronese, Silvio
    Tosi, Federica
    Maiolani, Martina
    Rospo, Giuseppe
    Truini, Mauro
    Bonoldi, Emanuela
    Christiansen, Jason
    Potts, Steven J.
    Siena, Salvatore
    Sartore-Bianchi, Andrea
    [J]. JOURNAL OF CLINICAL PATHOLOGY, 2018, 71 (10) : 926 - 931
  • [78] The molecular landscape of colorectal cancer cell lines unveils clinically actionable kinase targets
    Medico, Enzo
    Russo, Mariangela
    Picco, Gabriele
    Cancelliere, Carlotta
    Valtorta, Emanuele
    Corti, Giorgio
    Buscarino, Michela
    Isella, Claudio
    Lamba, Simona
    Martinoglio, Barbara
    Veronese, Silvio
    Siena, Salvatore
    Sartore-Bianchi, Andrea
    Beccuti, Marco
    Mottolese, Marcella
    Linnebacher, Michael
    Cordero, Francesca
    Di Nicolantonio, Federica
    Bardelli, Alberto
    [J]. NATURE COMMUNICATIONS, 2015, 6
  • [79] Identification and characterization of a novel SCYL3-NTRK1 rearrangement in a colorectal cancer patient
    Milione, Massimo
    Ardini, Elena
    Christiansen, Jason
    Valtorta, Emanuele
    Veronese, Silvio
    Bosotti, Roberta
    Pellegrinelli, Alessio
    Testi, Adele
    Pietrantonio, Filippo
    Fuca, Giovanni
    Wei, Ge
    Murphy, Danielle
    Siena, Salvatore
    Isacchi, Antonella
    De Braud, Filippo
    [J]. ONCOTARGET, 2017, 8 (33) : 55353 - 55360
  • [80] Non-small cell lung cancer: Epidemiology, risk factors, treatment, and survivorship
    Molina, Julian R.
    Yang, Piii G.
    Cassivi, Stephen D.
    Schild, Steven E.
    Adjei, Alex A.
    [J]. MAYO CLINIC PROCEEDINGS, 2008, 83 (05) : 584 - 594